Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Phase I clinical testing of experimental Ebola Vaccine VSVΔG-ZEBOV

Proposed period of release:
01/01/2014 to 31/12/2014

Name of the Institute(s) or Company(ies)
Universitätsklinikum Hamburg-Eppendorf, ;

3. Is the same GMO release planned elsewhere in the Community?
Not known

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
RNA Virus

Identity of the GMO:
Identity of the GMO (genus and species)
VSVΔG-ZEBOV, derivative of VSV Indiana, expressing instead of VSV-G the Zaire Ebola transmembrane glycoprotein (Garbutt et al., 2004)

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
VSVVesiculo virusVesicular stomatitis virusIndiana serotypeGI:9627229, GenBank Locus NC_001560

European Commission administrative information

Consent given by the Member State Competent Authority:
11/06/2014 00:00:00